• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Techcouver.com

 
  • News
  • Events
  • Interviews
  • Thought Leadership
  • Web Summit Vancouver
  • Jobs
  • About
    • Contact Us

Chinook Therapeutics

Canada’s Fastest-growing Life Sciences Sector Is Hiring

January 16, 2023 by Bulletin Board 1 Comment

With $1.3 billion of capital raised in 2021, B.C.’s life sciences sector has never been more robust. In fact, B.C. is Canada’s fastest-growing life sciences sector, employing roughly 20,000 people at over 2,000 companies. And according to BioTalent Canada’s 2021 National Report, the sector will likely require 65,000 additional workers by 2029. To help fill […]

Filed Under: Bulletin Board Tagged With: Acuitas Therapeutics, Chinook Therapeutics, Life Sciences BC, STEMCELL

Venture Capital Deal Activity Robust In B.C. During Q3 2020

November 30, 2020 by Techcouver Newsdesk Leave a Comment

Hockeystick has released their BC Tech Report for Q3 2020 that summarizes venture capital deal activity in Q3. COVID-19 has not slowed down deal activity in the region, but its impact can be seen in the types of companies raising funds, exemplified by Thinkific’s $22 million raise to address remote learning demand attributed to COVID-19 changes […]

Filed Under: News Tagged With: Attendease, Chinook Therapeutics, Conexiom, Craft Ventures, Dapper Labs, FoodX Technologies, HealthTech Connex, Ideon, Klue, Olive, Rhino Ventures, Thinkific, TIMIA Capital, Vanedge Capital, VodaSafe

LifeSciences BC Recognizes Annual Award Winners

September 16, 2020 by Bulletin Board

LifeSciences BC has announced the the recipients of the 22nd Annual LifeSciences BC Awards. The annual awards recognize talented individuals and organizations that represent the life sciences ecosystem in B.C. which includes academia, health institutions, research & development, SMEs, government, and industry. This year’s award winners represent the full spectrum from discovery to commercialization, underscoring […]

Filed Under: Bulletin Board Tagged With: adMare Bioinnovations, Canary Medical, Chinook Therapeutics, Life Sciences BC, Xenon Pharmaceuticals

Chinook Therapeutics Raises USD $106 Million In Advance of Merger

August 24, 2020 by Techcouver Newsdesk

Vancouver’s Chinook Therapeutics has raised a USD $106 million in a private placement financing that included top-tier healthcare investors. As part of the financing, Chinook’s existing investors, Versant Ventures, Apple Tree Partners and Samsara BioCapital, will purchase $25 million in Chinook common stock on the same terms as the new investors in lieu of their prior […]

Filed Under: News Tagged With: Chinook Therapeutics

Chinook Therapeutics Merges With Nasdaq-Traded Aduro Biotech

June 3, 2020 by Techcouver Newsdesk

Vancouver’s Chinook Therapeutics announced today that they are merging with Nasdaq-traded Aduro Biotech. Chinook is a privately held clinical-stage biotechnology company focused on the discovery, development and commercialization of precision medicines for kidney diseases. Last year Chinook raised a $65 million Series A round led by founding investor Versant Ventures. Under the merger agreement, Seattle-based […]

Filed Under: News Tagged With: Chinook Therapeutics

Eleven Vancouver Companies Included on Narwhal List

February 4, 2020 by Techcouver Newsdesk

The Narwhal Project identifies a set of young Canadian companies that have the potential to become successful on the world stage. The Narwhal List sheds light on the ability of firms to scale up and reach world-class status. 2019 was a remarkable year for Vancouver’s technology sector as there are eleven companies that made the cut. […]

Filed Under: News Tagged With: Carbon Engineering, Chinook Therapeutics, Clio, D-Wave Systems, Dapper Labs, General Fusion, Hootsuite, Lungpacer Medical, Mojio, Trulioo, Visier

Chinook Therapeutics Raises $65 Million to Bring Precision Medicine to the Kidney

August 23, 2019 by Techcouver Newsdesk Leave a Comment

Vancouver’s Chinook Therapeutics has raised a $65 million Series A financing round to discover and develop precision medicines for kidney diseases. Founding investor Versant Ventures led the round with participation by fellow founding investor Apple Tree Partners and new investor Samsara BioCapital. The Series A proceeds will fund the advancement of several kidney disease programs […]

Filed Under: News Tagged With: Chinook Therapeutics

Primary Sidebar

 

Stay Connected

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter

Community Partners

About Us

Techcouver provides real-time reporting and analysis of emerging technology news in Vancouver and throughout British … READ MORE... about About Us

Copyright © 2025 Incubate Ventures | Techtalent.ca · Decoder.ca · Calgary.tech · Fintech.ca · CleanEnergy.ca | Privacy